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A B S T R A C T The T cell proliferative response to au-
tologous non-T cells is termed the autologous mixed
lymphocyte reaction (AMLR). Recent studies have
suggested that the AMLRrepresents an inducer circuit
for the activation of T8+ suppressor/cytotoxic effector
cells. Since atopic dermatitis (AD) patients are defi-
cient in T8+ cytolytic T cell function, we investigated
the AMLRin AD. Whensheep erythrocytes were used
to separate T cells from non-T cells, the AMLRwas
found to be significantly decreased (P < 0.001) in AD
patients (n = 11; Acpm = 1,550±393) when compared
with normal control subjects (n = 13; Acpm
= 25,819±4,609). To exclude the possibility that these
results were an artifact of the sheep erythrocyte sep-
aration, T cells were also separated on a fluorescence-
activated cell sorter after treatment of peripheral
blood lymphocytes with the OKT3 monoclonal anti-
body. AD T cells separated by the latter method were
also found to have a significantly reduced AMLRre-
sponse when compared with similarly treated normal
T cells. Co-culture studies using cells from ADpatients
and their HLA identical siblings indicated that the
defect resided at the responder T cell level rather than
at the stimulator non-T cell level. Co-culture studies
revealed no evidence for excessive suppressor cell ac-
tivity resulting in the decreased AMLR. However, enu-
meration of T cells reactive with the monoclonal an-
tibody T29, which recognizes a subset of T cells pro-
liferating in the AMLR, demonstrated that ADpatients
(n = 8; %T29 = 2.5±0.7) had a significantly decreased
(P < 0.001) number of circulating T29+ T cells when
compared with normal controls (n = 8; % T29
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= 10.4±0.8). These studies suggest that a deficiency
of T4+ T29+ cells contributes to the deficient AMLR
in ADand possibly underlies the abnormalities of T8+
effector cells present in this disease.
INTRODUCTION
Defective cell-mediated immunity has been reported
in up to 80% of patients with atopic dermatitis (AD)'
(1-5). Clinically, these patients are susceptible to de-
velop disseminated viral infections with herpes sim-
plex and vaccinia viruses (5). This in vivo observation
correlates with in vitro experiments showing that the
majority of ADpatients are unable to generate normal
T8+ cytotoxic T cell activity after allogeneic stimu-
lation (6). Furthermore, the latter study also demon-
strated that the defect in generation of cytotoxic T
cells resided in both the helper/inducer T4+ cells and
the effector T8+ cells. Since recent studies suggest that
the autologous mixed lymphocyte reaction (AMLR)
represents an inducer circuit for the activation of T8+
effector cells (7), the current investigation was carried
out to determine whether AD patients had a defective
AMLRand, if so, to determine the cellular basis of this
defect.
METHODS
Subjects. The study population consisted of 16 patients
with chronic AD, nine males and seven females, 4-40 yr of
age. They all satisfied the criteria suggested by Hanifin and
Lobitz (5) for the diagnosis of AD, and had moderate to
severe chronic AD defined by multiple sites of skin involve-
ment for at least 3 mo, as well as a personal and/or family
' Abbreviations used in this paper: AD, atopic dermatitis;
AMLR, autologous MLR; E, sheep erythrocyte; MLR, mixed
lymphocyte reaction; PBMC, peripheral blood mononuclear
cells.
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history of allergic diseases. Two age-matched control pop-
ulations were studied: the first consisted of 15 healthy sub-
jects, nine males and six females, 6-36 yr of age, with no
skin disease; the second control population consisted of five
patients with nonatopic skin disease (Netherton's disease,
psoriasis, and pityriasis rosea: one each, and inflammatory
acne: two patients) aged 5-25 yr. Consent was obtained ei-
ther from subjects or from their parents before obtaining
blood. None of the individuals studied had previously re-
ceived oral steroids, and topical corticosteroids were held for
at least 1 wk before the study.
Isolation of peripheral blood mononuclear cell (PBMC).
PBMCwere isolated from heparinized venous blood by
means of Ficoll-Hypaque gradient density centrifugation
and incubated on plastic petri dishes for 30 min at 370C to
remove excess macrophages, which have been shown to sup-
press the AMLR (7). The nonadherent cells were rosetted
with sheep erythrocytes (E) and fractionated into T cells
(E+) and non-T cells (E-) as previously described (8).
AMLRand allogeneic mixed lymphocyte reaction (MLR).
AMLRcultures contained 1 X 105 responder E+ cells and
1 X 105 irradiated (5,000 R) stimulator E- cells in 200 jAl
of complete culture medium (RPMI 1640 with 10% AB+,
2 mML-glutamine, 10-6 M indomethacin, 50 ,g penicillin,
and 50 ,g streptomycin/ml). Cultures were performed for
6 d at 37°C in humidified 5% CO2. 18 h before termination
of the cultures, 1 MCi [3H]thymidine (New England Nuclear,
Boston, MA) was added to each culture. Results were ex-
pressed as mean counts per minute±SEM of triplicate cul-
tures minus background counts per minute (cultures of au-
tologous T cells and irradiated autologous T cells), i.e.,
Acpm. Allogeneic MLR were performed in an identical
manner, except that 1 X 105 irradiated allogeneic non-T cells
were used as stimulators. To determine whether T cells sup-
pressive of the AMLRwere present, 5 X 104 cells from the
patient were added to the AMLRof a healthy HLA-identical
sibling.
In selected experiments, T cells were separated from non-
T cells on the basis of reactivity with the OKT3 (Ortho Phar-
maceutical, Raritan, NJ) monoclonal antibody. Nonadherent
PBMCwere incubated with OKT3antibody (10 X 106 cells/
,ug antibody in 0.2 ml RPMI with 1% human serum albumin)
for 45 min on ice, washed twice, and incubated at 4°C for
30 min with 1:40 dilution of fluorescein-conjugated goat anti-
mouse IgG (Cappel Laboratories, Cochranville, PA). After
washing the cells three times, T3-positive (T3+) T cells were
separated from T3-negative (T3-) non-T cells on a fluores-
cence-activated cell sorter (FACS)-IV cell sorter (Becton,
Dickinson & Co., Mountain View, CA). At the end of the
cell-sort, T3+ cells and T3- cells were washed once, resus-
pended at 1 X 106 cells/ml complete culture medium, and
AMLRcultures were set up as described above.
Analysis of peripheral blood T lymphocytes with T29
monoclonal antibody. The T29 monoclonal antibody was
previously shown to react with 10% of peripheral blood
T cells and to define a subpopulation of T cells that prolif-
erate during the AMLR(9). 1 million T lymphocytes were
suspended in 0.1 ml of T29 monoclonal antibody (generous
gift of Dr. J. Stobo, San Francisco, CA) or with 0.1 ml of
1:10 dilution of mouse serum at 4°C for 40 min, washed
once, and incubated at 4°C for 30 min with 0.1 ml of a 1:20
dilution of fluorescein-conjugated goat anti-mouse IgG. Af-
ter washing the cells three times, cytofluorographic analysis
was performed on a FACS-IV. Uniformly, <2% of the cells
exhibited fluorescent staining with the reagent control.
RESULTS
Impaired autologous MLR in AD. Results of the
AMLRafter separation of T cells by E in AD patients
are shown in Fig. 1. The mean AMLRof 13 normal
age-matched controls was 25,819±4,609 cpm above
background. The AMLRof 11 AD patients averaged
only 1,550±392 cpm and was significantly depressed
(P < 0.01) compared with normal subjects and controls
(P < 0.001). In contrast, the AMLR in five subjects
with miscellaneous skin diseases was not significantly
different from the normals (P > 0.1). There was no
significant difference between background cpm in AD
subjects and control subjects. Although the results ob-
tained for each patient are represented only once in
Fig. 1, several patients and normal controls were tested
on multiple occasions (up to five times) over a 1-yr
period and the results were unchanged. Furthermore,
in two AD patients studied on multiple occasions, the
AMLRremained abnormally low regardless of whether
they were in short term remission (<6 mo) or had
active skin disease.
The AMLRresponse of three AD patients and four
normal controls were also determined after separation
of T3+ T cells from T3- non-T cells in a FACS-IV
cell sorter. As shown in Table I, separation of T cells
on the basis of reactivity with the OKT3 monoclonal
antibody resulted in similar results as those obtained
by separating T cells using E, i.e., the mean AMLR
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FIGURE 1 AMLRin 11 AD patients, 13 normal subjects, and
five patients with nonatopic skin diseases. Results of the
AMLRare expressed as the mean±SEMof triplicate cultures.
The AMLR of AD patients was significantly below (P
< 0.001) that of normal controls.




AMLRafter Cell Sort with OKT3 Monoclonal Antibody
AMLR(Acpm)





Mean AMLR 24,685±5,534 4,169±205
The AMLRresponse of four normal donors and three AD patients
were determined after T cells were separated from non-T cells by
cell sorting PBMCfor T3+ cells on a FACS-IV cell sorter. Results
are expressed as mean±SEMof triplicate cultures. The AMLRof
AD patients was significantly below (P < 0.02) that of normal
controls.
nificantly lower than that of normal controls (Acpm
= 24,685±5,534; P < 0.02). These results suggest that
the basis for the decreased AMLRin AD was not due
to an abnormal proliferative response to E antigens.
In contrast to the impairment of the AMLR, allo-
geneic MLR in patients with AD was normal. Allo-
geneic MLRdetermined in eight out of the 11 patients
with AD (mean±SEM of Acpm = 54,524±10,047) was
not significantly different (P > 0.3) from the allogeneic
MLRdetermined in eight control subjects (mean±SEM
of Acpm = 60,107±7,902).
Cellular basis of the impaired AMLRin AD. To
determine whether the impaired AMLRwas due to
a defect of responder T cells, stimulator cells, or both,
two AD patients and their healthy HLA-identical sib-
lings were studied. In these experiments, T cells from
a patient, from an HLA-A-, B-, and DR-identical sib-
ling and from an unrelated normal subject were cul-
tured with non-T cells from each of these three donors.
The results in Table II show that T cells from the
healthy HLA-identical siblings were stimulated equally
well by autologous non-T cells and by the patient's
non-T cells (Table II, lines 2 and 5, columns 3 and 4).
In contrast, T cells from the patients did not proliferate
in response to either autologous non-T cells or HLA-
identical normal non-T cells (Table II, lines 1 and 4,
columns 3 and 4). These results suggested that the
defect in AD patients resided at the level of the re-
sponder T-cell, rather than at the level of the stimu-
lator non-T cells. The deficiency in T cell response was
not generalized because the patients' T cells response
to allogeneic non-T cells was equivalent to that of T
cells from their HLA-identical siblings (Table II, col-
umn 5).
The possibility that suppressor T cells were respon-
sible for the decreased AMLR in AD was tested by
studying the effect of the addition of T cells from two
AD patients to the AMLRof their healthy HLA-iden-
tical siblings. As shown in Fig. 2, T cells from AD
patients did not possess excessive suppressor cell ac-
tivity for the AMLR. These was no significant differ-
ence (P > 0.1) in proliferation when normal T cells
were stimulated with autologous non-T cells in the
presence of absence of HLA-identical AD T cells.
Enumeration of T29 cells in AD. The possibility
that the decreased AMLRin AD was accompanied by
a numerical reduction of autoreactive T cells was con-
sidered. To test this possibility, T cells from normal
controls and AD patients were enumerated for reac-
tivity with the T29 monoclonal antibody, previously
shown to react with a subpopulation of T cells that
proliferate in the AMLR. As shown in Fig. 3, the T29
antigen was present on 10.4±0.8% of normal T cells
TABLE II
Defective T Cell Response in the AMLRof Patients with AD
[H]thymidine incorporated in the presence of stimulator non-T cells
HLA-identical
Experiment Responder T cells Patient sibling Unrelated donor
cpm
A Patient 1 965±143 2,499±80 148,028±1,900
HLA-identical sibling 68,475±7,783 63,651±1,553 146,598±13,400
Unrelated donor 149,326±13,476 163,940±10,541
B Patient 2 120±27 226±80 58,983±10,930
HLA-identical sibling 27,247±252 28,568±2,552 34,176±6,038
Unrelated donor 51,276±2,815 66,110±3,304
Results reported as the mean±SEMof triplicate cultures.
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FIGURE 2 Effect of HLA-identical ADT cells on the normal
AMLRresponse. To determine whether the defective AMLR
in AD is due to the presence of excessive suppressor T cell
activity, AMLRcultures of normal HLA-identical siblings
were carried out in the presence or absence of AD T cells.
Results shown in this table are derived from two ADpatients
and demonstrate that AD T cells do not possess excessive
suppressor activity for the AMLR. NL, normal leukocyte.
(n = 8). In contrast, patients with AD (n = 8) had
significantly decreased percentage of circulating T29
positive cells (2.5±0.7%, P < 0.001). Since patients
with AD have normal or decreased numbers of cir-
culating T cells (10, 11), these results suggest that the
absolute number of circulating T29+ cells is also de-
creased in AD.
vestigator-s have demonstrated that the decreased
AMLRin Hodgkins' Disease (12) and systemic lupus
erythematosus (13) may be due to defective responder
T cells, whereas a defect of autologous stimulator cells
has been described in patients with mononucleosis (14)
and chronic lymphocytic leukemia (15).
The T cell defect in AMLRwas neither generalized
nor appeared to be the result of excess suppressor cells.
Indeed, T cells from patients with AD proliferated
normally to allogeneic cells. Suppression of the AMLR
by non-T cells was not a factor, since non-T cells from
the patients were excellent stimulators of HLA-iden-
tical normal T cells (Table II). Suppression by T cells
was tested for and ruled out in co-culture experiments
in which T cells from AD patients were added to the
AMLRof their normal HLA-identical siblings (Fig. 2).
The defective AMLR in AD could have resulted
from a functional and/or numerical impairment of T
cells committed to the AMLR. Two subpopulations of
T cells are known to paticipate in the AMLR. One
population bears the surface antigen recognized by the
T29 monoclonal antibody and proliferates in response
to adherent monocytes. A second population lacks the
T29 surface antigen and responds to nonadherent E-
cells, i.e., B cells and null cells (7). Our studies show
a deficiency in the T29+ population in AD (Fig. 2).
The major portion of the proliferative AMLRresponse
is due to T29- cells (7, 9). Because the mean AMLR
of AD patients was <10% of the normal AMLR, it is
DISCUSSION
Our data indicate that the T cells of patients with AD
respond poorly to autologous non-T cells. Similar re-
sults were obtained whether T cells were separated on
the basis of rosetting with E or cell sorting after treat-
ment with the OKT3 monoclonal antibody. The de-
fective AMLRin AD was not simply secondary to the
skin inflammation, because other patients with skin
disease had normal AMLR(Fig. 1) and because, in two
patients with AD who were studied on multiple oc-
casions, impaired AMLRwas present even during short
term remissions (<6 mo), i.e., when they had no evi-
dence of skin disease.
Reciprocal mixing experiments using cells from the
patients and from their healthy HLA-identical siblings
indicated that a defect in responder T cells rather than
in stimulator non-T cells was the basis of the defective
AMLRin AD. Indeed, in each of two cases studied,
T cells from the healthy HLA-identical sibling mounted
normal proliferative responses to both autologous and
AD non-T cells. Patients' T cells, however, failed to
respond to either autologous or normal sibling's non-





















FIGURE 3 Enumeration of T29+ cells in AD. T lymphocytes
from eight AD patients and eight healthy controls were an-
alyzed for reactivity with the T29 monoclonal antibody pre-
viously shown to recognize a subset of T cells that proliferate
during the AMLR. AD patients had a significantly lower
percentage of T29+ cells (P < 0.001) than normals. The
mean±SEMof each group is shown.
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likely that the T29- population as well as the T29+
cells were deficient (functionally and/or numerically).
The deficient AMLRin patients with AD has to be
viewed in the context of other immunoregulatory ab-
normalities present in this disease and in the light of
the cellular events that occur in the AMLR. The subset
of AMLRreactive T cells includes T cells that prolif-
erate in response to soluble antigens (9). In this regard,
lymphocytes from AD patients proliferate poorly in
response to candida and tuberculin antigens (16). Iso-
lated T4+ cells proliferate in the AMLRwhereas iso-
lated T8+ cells do not (17, 18). However, in the pres-
ence of T4+ cells, T8+ cells will proliferate; this sug-
gests that the AMLRcan function as an inducer circuit
for the activation of T8+ effector cells (17). A variety
of effector functions have been attributed to AMLR-
activated T cells. They include the induction of cy-
totoxic T cells (19, 20), of helper T cells (21, 22), and
of suppressor T cells (12, 23). In this regard the ma-
jority of patients with AD are deficient in T8+ cyto-
lytic T cell function (6). This deficiency has been
shown to be due in part to the failure of their T4+
helper cells to induce normal T8+ cytotoxic T cell
function (6). Further studies are required to delineate
the relationship between the deficient AMLRand im-
paired induction of cytolytic T cells in patients
with AD.
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